Literature DB >> 21139214

Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide.

Min Y Yap1, Matthew C J Wilce, Daniel J Clayton, Patrick Perlmutter, Marie-Isabel Aguilar, Jacqueline A Wilce.   

Abstract

Grb7 is an adapter protein that is involved in signalling pathways that mediate eukaryotic cell proliferation and migration. Its overexpression in several cancer types has implicated it in cancer progression and led to the development of the G7-18NATE cyclic peptide inhibitor. Here, the preparation of crystals of G7-18NATE in complex with its Grb7 SH2 domain target is reported. Crystals of the complex were grown by the hanging-drop vapour-diffusion method using PEG 3350 as the precipitant at room temperature. X-ray diffraction data were collected from crystals to 2.4 Å resolution using synchrotron X-ray radiation at 100 K. The diffraction was consistent with space group P2(1), with unit-cell parameters a=52.7, b=79.1, c=54.7 Å, α=γ=90.0, β=104.4°. The structure of the G7-18NATE peptide in complex with its target will facilitate the rational development of Grb7-targeted cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139214      PMCID: PMC2998373          DOI: 10.1107/S1744309110041850

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

1.  Integration of macromolecular diffraction data.

Authors:  A G Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-10

Review 2.  Molecular recognition by SH2 domains.

Authors:  J Michael Bradshaw; Gabriel Waksman
Journal:  Adv Protein Chem       Date:  2002

Review 3.  Grb7 in intracellular signaling and its role in cell regulation.

Authors:  Tang-Long Shen; Jun-Lin Guan
Journal:  Front Biosci       Date:  2004-01-01

4.  NMR analysis of G7-18NATE, a nonphosphorylated cyclic peptide inhibitor of the Grb7 adapter protein.

Authors:  C J Porter; J A Wilce
Journal:  Biopolymers       Date:  2007       Impact factor: 2.505

5.  Association of focal adhesion kinase with Grb7 and its role in cell migration.

Authors:  D C Han; J L Guan
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

6.  Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

Authors:  Shinji Tanaka; Stephanie C Pero; Kenichi Taguchi; Mitsuo Shimada; Masaki Mori; David N Krag; Shigeki Arii
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

7.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

8.  The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.

Authors:  D Stein; J Wu; S A Fuqua; C Roonprapunt; V Yajnik; P D'Eustachio; J J Moskow; A M Buchberg; C K Osborne; B Margolis
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

9.  Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells.

Authors:  S C Pero; G S Shukla; M M Cookson; S Flemer; D N Krag
Journal:  Br J Cancer       Date:  2007-04-10       Impact factor: 7.640

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.